O'Neil Global Advisors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$835K Buy
+4,335
New +$467K 0.32% 35

Other funds holding MRNA

O'Neil Global Advisors's MRNA Position: Q3 2026 in Review

O'Neil Global Advisors opened a new position in Moderna (MRNA) in Q3 2026: 4,335 shares worth $835K. The stake represents 0.32% of the portfolio and ranks #35 among its holdings.

1,048 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • O'Neil Global Advisors held 4,335 shares of Moderna worth $835K as of Q3 2026.
  • Moderna was a new O'Neil Global Advisors position in Q3 2026.
  • Moderna made up 0.32% of O'Neil Global Advisors's portfolio in Q3 2026, its #35 holding.
  • 1,048 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on O'Neil Global Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.